Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Sucampo Pharmaceuticals Inc (NASDAQ:SCMP)

12.42
Delayed Data
As of May 27
 +0.67 / +5.70%
Today’s Change
9.59
Today|||52-Week Range
29.67
-28.17%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 2
2015
Quarter 3
2015
Quarter 4
2015
Quarter 1
2016
Revenue and IncomeNet Revenues34.9M33.4M55.4M47.2M
 
 
 
 
 
Cost of Goods Sold7.1M5.1M7.9M7.8M
 
 
 
 
 
Depreciation And Amortization132.0K218.0K10.1M15.6M
 
 
 
 
 
 
Operating ExpensesGross Income27.6M28.2M37.3M23.9M
 
 
 
 
 
General Expenses16.0M16.5M25.7M24.2M
 
 
 
 
 
Research And Development7.1M8.4M11.3M14.7M
 
 
 
 
 
Total Operating Expenses23.3M21.8M43.8M47.5M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income11.6M11.7M11.6M-320.0K
 
 
 
 
 
Extraordinary Charge0.000.000.00-183.0K
 
 
Interest Expense On Debt265.0K243.0K6.1M6.3M
 
 
 
 
 
Other Expenses2.1M87.0K3.9M-347.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income13.4M11.6M9.5M-7.1M
 
 
 
 
 
Income Taxes-3.9M-4.3M-685.0K-3.0M
 
 
 
 
 
Net Income9.6M7.2M10.2M-4.1M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS44.6M44.7M42.9M42.5M
 
 
 
 
 
Shares To Calculate EPS Diluted46.2M46.3M44.3M42.5M
 
 
 
 
 
 
Earnings Per ShareEPS$0.21$0.16$0.23-$0.10
 
 
 
 
 
EPS Diluted$0.21$0.16$0.23-$0.10